Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $449.75 | 2 | 56.8% |
| Food and Beverage | $341.67 | 3 | 43.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $449.75 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $125.00 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 1 | $0 (2018) |
| Amgen Inc. | $91.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $574.75 | 3 | Novartis Pharmaceuticals Corporation ($449.75) |
| 2017 | $216.67 | 2 | Merck Sharp & Dohme Corporation ($125.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2018 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 06/04/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | LAG525 (Drug) | — | In-kind items and services | $335.15 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT | ||||||
| 02/13/2018 | Novartis Pharmaceuticals Corporation | LAG525 (Drug) | — | In-kind items and services | $114.60 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT | ||||||
| 04/13/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2017 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $91.67 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $335.15 | 1 |
| RESEARCH RELATED PUBLICATION SUPPORT | Novartis Pharmaceuticals Corporation | $114.60 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 168 | 522 | $302,855 | $47,281 |
| 2022 | 5 | 194 | 570 | $319,030 | $52,043 |
| 2021 | 4 | 189 | 641 | $355,435 | $59,867 |
| 2020 | 8 | 262 | 680 | $335,680 | $51,360 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 467 | $254,515 | $39,555 | 15.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $27,170 | $4,029 | 14.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 29 | $21,170 | $3,697 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 446 | $243,070 | $38,967 | 16.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 70 | $36,750 | $6,529 | 17.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $26,125 | $4,302 | 16.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 13 | 13 | $7,085 | $1,249 | 17.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 16 | $6,000 | $995.89 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 524 | $285,580 | $48,027 | 16.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 71 | $35,855 | $6,751 | 18.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 25 | 25 | $26,125 | $3,861 | 14.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 21 | $7,875 | $1,228 | 15.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 119 | 474 | $246,480 | $34,285 | 13.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 27 | 69 | $34,155 | $6,669 | 19.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 18 | 18 | $17,820 | $2,845 | 16.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 29 | $20,010 | $2,806 | 14.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 32 | 41 | $6,365 | $1,969 | 30.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 17 | $3,485 | $1,253 | 35.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 17 | 17 | $5,865 | $1,160 | 19.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 13 | 15 | $1,500 | $373.16 | 24.9% |
About Dr. Chrisann Kyi, M.D
Dr. Chrisann Kyi, M.D is a Medical Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1043509912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chrisann Kyi, M.D has received a total of $791.42 in payments from pharmaceutical and medical device companies, with $574.75 received in 2018. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "" ($449.75).
As a Medicare-enrolled provider, Kyi has provided services to 813 Medicare beneficiaries, totaling 2,413 services with total Medicare billing of $210,550. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location New York, NY
- Active Since 03/31/2011
- Last Updated 11/15/2022
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1043509912
Products in Payments
- LAG525 (Drug) $449.75
- KEYTRUDA (Biological) $125.00
- XGEVA (Biological) $91.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in New York
Craig Thompson, Md, MD
Medical Oncology — Payments: $2.1M
Andrew Seidman, Md, MD
Medical Oncology — Payments: $1.7M
Dr. Joshua Richter, M.d, M.D
Medical Oncology — Payments: $1.6M
Ghassan Abou-Alfa, Md, MD
Medical Oncology — Payments: $1.2M
Edward Gelmann
Medical Oncology — Payments: $944,679
Miguel Perales, Md, MD
Medical Oncology — Payments: $759,555